CVE-2026-123218

CRITICALCVSS 9.8/10Actively ExploitedEPSS 0.40%

Last modified

CVE-2026-123218 is a critical-severity vulnerability rated 9.8/10 on the CVSS scale. IBM Aspera Faspex 5.0.0 through 5.0.19 could allow an authorized user to craft a specific message to bypass user authorization and gain full administrative privileges.. CISA has confirmed active exploitation in the wild. EPSS estimates a 0.40% chance of exploitation in the next 30 days.

Description

IBM Aspera Faspex 5.0.0 through 5.0.19 could allow an authorized user to craft a specific message to bypass user authorization and gain full administrative privileges.

Metrics

EPSS Probability
0.40%

34.1th percentile

Probability of exploitation in the next 30 days. Learn more

Exploitation Status

This vulnerability is listed in CISA’s Known Exploited Vulnerabilities catalog, confirming active exploitation in the wild. Federal agencies must remediate by .

Weakness Enumeration

Affected Software

VendorProductVersions
IbmAspera Faspex>= 5.0.0, < 5.0.19.1

References

Timeline

Published
Last Modified
Status
Analyzed

Frequently Asked Questions

What is CVE-2026-123218?
IBM Aspera Faspex 5.0.0 through 5.0.19 could allow an authorized user to craft a specific message to bypass user authorization and gain full administrative privileges.
How severe is CVE-2026-123218?
CVE-2026-123218 has a CVSS score of 9.8/10 (CRITICAL severity). The EPSS model estimates a 0.40% probability of exploitation in the next 30 days. This vulnerability is listed in CISA's Known Exploited Vulnerabilities catalog.
How do I fix CVE-2026-123218?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

How Strix Helps

Related CVEs from 2026

Are you affected by CVE-2026-123218?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST